{"The DEA recently approved a new oral liquid formulation of dronabinol": "a synthetic version of the active ingredient in marijuana, as a Schedule II drug.", "The approval of this synthetic version of THC is not the first time the DEA has approved dronabinol": "which is different from recreational \"synthetic cannabis\" products.", "The United States Food and Drug Administration": "FDA) approved a New Drug Application for Syndros, an oral solution of the synthetic version of the most prominent psychoactive ingredient in marijuana, for use by AIDS and chemotherapy patients.", "The DEA issued a ruling on Syndros": "placing it in the Schedule II grouping of drugs with a high potential for abuse, allowing for prescription in a limited fashion. This ruling was adopted in a final form without changes."}